糖尿病腎症の世界市場レポート 2024年

糖尿病腎症の市場規模は近年力強く成長しています。2023年の25億1,000万米ドルから2024年には26億5,000万米ドルに、CAGR5.7％で拡大します。実績期間の成長は、糖尿病合併症の早期把握、診断技術の進歩、ACE阻害薬やARBの開発、臨床試験や治療プロトコール、ガイドラインや疾患管理プロトコールの確立などに起因しています。

2023年の糖尿病腎症市場で最大の地域は北米でした。糖尿病腎症市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 糖尿病腎症市場の特徴

第3章 糖尿病腎症市場の動向と戦略

第4章 糖尿病腎症市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の糖尿病腎症市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 糖尿病腎症市場セグメンテーション

• 世界の糖尿病腎症市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 1型糖尿病
• 2型糖尿病
• 世界の糖尿病腎症市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• アンジオテンシン受容体拮抗薬（ARB）
• アンジオテンシン変換酵素（Ace）阻害剤
• 抗酸化炎症調節剤
• カルシウムチャネルブロッカー
• その他の治療法
• 世界の糖尿病腎症市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• ホームケア
• 専門センター
• その他のエンドユーザー

第7章 糖尿病腎症市場の地域および国分析

• 世界の糖尿病腎症市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の糖尿病腎症市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋の糖尿病腎症市場

第9章 中国の糖尿病腎症市場

第10章 インドの糖尿病腎症市場

第11章 日本の糖尿病腎症市場

第12章 オーストラリアの糖尿病腎症市場

第13章 インドネシアの糖尿病腎症市場

第14章 韓国の糖尿病腎症市場

第15章 西欧の糖尿病腎症市場

第16章 英国の糖尿病腎症市場

第17章 ドイツの糖尿病腎症市場

第18章 フランスの糖尿病腎症市場

第19章 イタリアの糖尿病腎症市場

第20章 スペインの糖尿病腎症市場

第21章 東欧の糖尿病腎症市場

第22章 ロシアの糖尿病腎症市場

第23章 北米の糖尿病腎症市場

第24章 米国の糖尿病腎症市場

第25章 カナダの糖尿病腎症市場

第26章 南米の糖尿病腎症市場

第27章 ブラジルの糖尿病腎症市場

第28章 中東の糖尿病腎症市場

第29章 アフリカの糖尿病腎症市場

第30章 糖尿病腎症市場の競合情勢と企業プロファイル

• 糖尿病腎症市場の競合情勢
• 糖尿病腎症市場企業プロファイル
  • AstraZeneca plc
  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • Sanofi SA

第31章 世界の糖尿病腎症市場の競合ベンチマーキング

第32章 世界の糖尿病腎症市場競争ダッシュボード

第33章 糖尿病腎症市場における主要な合併と買収

第34章 糖尿病腎症市場の将来展望と可能性分析

第35章 付録

“Diabetic Kidney Disease Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetic kidney disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetic kidney disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The diabetic kidney disease market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Type 1 Diabetes; Type 2 Diabetes
• 2) By Treatment: Angiotensin Receptor Blockers (Arbs); Angiotensin-Converting Enzyme (Ace) Inhibitors; Antioxidant Inflammation Modulator; Calcium Channel Blockers; Other Treatments
• 3) By End User: Hospitals; Homecare; Specialty Centers; Other End Users
• Companies Mentioned: AstraZeneca plc; Pfizer Inc.; Novartis AG; Bayer AG; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Diabetic kidney disease is a form of renal disease resulting from complications of diabetes, where elevated blood sugar levels lead to kidney damage. The kidneys' blood vessels can be adversely affected by high blood glucose, reducing their functionality.

The primary types of diabetic kidney disease are associated with both type 1 and type 2 diabetes. Type 1 diabetes is a chronic autoimmune condition characterized by minimal or no insulin production by the pancreas. This deficiency leads to elevated blood sugar levels, causing damage to the nephrons and renal blood vessels. Managing blood sugar levels in type 1 diabetes often requires daily insulin injections. Treatment for diabetic kidney disease includes interventions such as angiotensin receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, antioxidant inflammation modulators, calcium channel blockers, and other medical approaches provided in facilities such as hospitals, homecare, specialty centers, and more.

The diabetic kidney disease market research report is one of a series of new reports from The Business Research Company that provides diabetic kidney disease market statistics, including global market size, regional shares, competitors with a diabetic kidney disease market share, detailed diabetic kidney disease market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic kidney disease industry. This diabetic kidney disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diabetic kidney disease market size has grown strongly in recent years. It will grow from $2.51 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to the early comprehension of diabetes complications, advancements in diagnostic techniques, the development of ACE inhibitors and ARBs, clinical trials and treatment protocols, and the establishment of guidelines and disease management protocols.

The diabetic kidney disease market size is expected to see strong growth in the next few years. It will grow to $3.29 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to personalized medicine and biomarker development, the rising global incidence of diabetes, a focus on disease modification therapies, the adoption of telehealth and remote care, and changes in healthcare policy and reimbursement. Major trends in the forecast period include advancements in renal replacement therapies, a precision medicine approach, a focus on early detection and diagnosis, therapeutic advancements, and an emphasis on comorbidities management.

The anticipated surge in chronic kidney disease (CKD) cases is set to drive the expansion of the diabetic kidney disease market. CKD, a prolonged condition leading to gradual kidney function loss, manifests various complications such as high blood pressure, anemia, and bone diseases. Effective management of CKD necessitates diagnostic and treatment solutions, thereby stimulating growth in the diabetic kidney disease market. According to a 2021 report from the Centers for Disease Control and Prevention (CDC), over 37 million individuals were estimated to suffer from CKD in the USA, notably prevalent among adults aged 65 and above, with approximately 38% experiencing some form of kidney damage. This rise in CKD instances significantly contributes to the burgeoning diabetic kidney disease market.

The upsurge in healthcare expenditure is poised to propel the diabetic kidney disease market's growth trajectory. Healthcare expenditure denotes the total spending on healthcare-related goods and services within a specific period, often on a national or institutional scale. Increased healthcare investment facilitates the adoption of cutting-edge diagnostic technologies, enabling early and precise detection of diabetic kidney disease and prompt intervention. The 2021-2030 National Health Expenditure (NHE) report released by the Centers for Medicare & Medicaid Services in March 2022 projects an average annual growth of 5.1% in national health spending, reaching nearly $6.8 trillion by 2030. Notably, Medicare spending is forecasted to increase by 7.2% annually, and Medicaid spending by 5.6% annually from 2021 to 2030. Consequently, escalating healthcare expenditure serves as a driving force behind the diabetic kidney disease market's expansion.

Technological advancements emerge as a pivotal trend gaining traction in the diabetic kidney disease market. Companies within this sector embrace novel technologies to fortify their market standing. For instance, in August 2022, Bloom Diagnostics, a US-based organization specializing in diagnostics and healthcare devices, introduced the Bloom Kidney Test. Integrated with the Bloom Smart System, this diagnostic tool evaluates kidney health by measuring cystatin C levels-a reliable indicator of kidney function. Categorizing kidney function into three stages-normal, mildly decreased, and decreased-the Bloom Kidney Test leverages cloud-based algorithms and AI technology within the Bloom Smart System. This integration combines test outcomes with pertinent health data such as medical history, lifestyle, and patient symptoms, facilitating comprehensive analysis and management.

Leading companies in the diabetic kidney disease market are actively innovating by developing new products such as medications tailored for chronic kidney disease (CKD), aiming for wider customer reach, increased sales, and revenue growth. These medications for CKD primarily focus on symptom management, slowing disease progression, and addressing complications arising from impaired kidney function. For instance, Bayer AG, a Germany-based pharmaceutical company, introduced Kerendia in August 2022-a medication specifically designed to manage CKD associated with diabetes. Kerendia stands out as a non-steroidal, selective mineralocorticoid receptor antagonist, uniquely tailored for individuals with chronic kidney disease linked to type-II diabetes. Offering a distinctive treatment approach, Kerendia holds promise in slowing CKD progression and reducing the risk of kidney failure in this susceptible patient group.

In January 2023, AstraZeneca, a UK-based biotech and pharmaceutical giant, finalized the acquisition of Cincor Pharma Inc. for an undisclosed sum. This strategic move strengthens AstraZeneca's cardiorenal pipeline by integrating CinCor's baxdrostat (CIN-107), an aldosterone synthase inhibitor (ASI) aimed at lowering blood pressure in treatment-resistant hypertension. Cincor Pharma Inc., a US-based biopharmaceutical company, specializes in developing drugs for kidney disease management. AstraZeneca's acquisition bolsters its portfolio by incorporating innovative solutions such as baxdrostat, further solidifying its position in addressing cardiorenal complications and advancing therapeutic options for kidney disease management.

Major companies operating in the diabetic kidney disease market report are AstraZeneca plc, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson pvt. Ltd., Eli Lilly and Company, Allergan Inc., Endo International Inc., GlaxoSmithKline plc, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals plc, Fresenius Kabi AG, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd

North America was the largest region in the diabetic kidney disease market in 2023. The regions covered in the diabetic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the diabetic kidney disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetic kidney disease market includes revenues earned by entities by providing diabetic kidney disease treatments for kidney stones, kidney infection, polycystic kidney disease, and kidney cysts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Diabetic Kidney Disease Market Characteristics

3. Diabetic Kidney Disease Market Trends And Strategies

4. Diabetic Kidney Disease Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Diabetic Kidney Disease Market Size and Growth

• 5.1. Global Diabetic Kidney Disease Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Diabetic Kidney Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Diabetic Kidney Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Diabetic Kidney Disease Market Segmentation

• 6.1. Global Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Type 1 Diabetes
• Type 2 Diabetes
• 6.2. Global Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Angiotensin Receptor Blockers (Arbs)
• Angiotensin-Converting Enzyme (Ace) Inhibitors
• Antioxidant Inflammation Modulator
• Calcium Channel Blockers
• Other Treatments
• 6.3. Global Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Homecare
• Speciality Centres
• Other End Users

7. Diabetic Kidney Disease Market Regional And Country Analysis

• 7.1. Global Diabetic Kidney Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Diabetic Kidney Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Diabetic Kidney Disease Market

• 8.1. Asia-Pacific Diabetic Kidney Disease Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Diabetic Kidney Disease Market

• 9.1. China Diabetic Kidney Disease Market Overview
• 9.2. China Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Diabetic Kidney Disease Market

• 10.1. India Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Diabetic Kidney Disease Market

• 11.1. Japan Diabetic Kidney Disease Market Overview
• 11.2. Japan Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Diabetic Kidney Disease Market

• 12.1. Australia Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Diabetic Kidney Disease Market

• 13.1. Indonesia Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Diabetic Kidney Disease Market

• 14.1. South Korea Diabetic Kidney Disease Market Overview
• 14.2. South Korea Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Diabetic Kidney Disease Market

• 15.1. Western Europe Diabetic Kidney Disease Market Overview
• 15.2. Western Europe Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Diabetic Kidney Disease Market

• 16.1. UK Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Diabetic Kidney Disease Market

• 17.1. Germany Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Diabetic Kidney Disease Market

• 18.1. France Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Diabetic Kidney Disease Market

• 19.1. Italy Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Diabetic Kidney Disease Market

• 20.1. Spain Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Diabetic Kidney Disease Market

• 21.1. Eastern Europe Diabetic Kidney Disease Market Overview
• 21.2. Eastern Europe Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Diabetic Kidney Disease Market

• 22.1. Russia Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Diabetic Kidney Disease Market

• 23.1. North America Diabetic Kidney Disease Market Overview
• 23.2. North America Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Diabetic Kidney Disease Market

• 24.1. USA Diabetic Kidney Disease Market Overview
• 24.2. USA Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Diabetic Kidney Disease Market

• 25.1. Canada Diabetic Kidney Disease Market Overview
• 25.2. Canada Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Diabetic Kidney Disease Market

• 26.1. South America Diabetic Kidney Disease Market Overview
• 26.2. South America Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Diabetic Kidney Disease Market

• 27.1. Brazil Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Diabetic Kidney Disease Market

• 28.1. Middle East Diabetic Kidney Disease Market Overview
• 28.2. Middle East Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Diabetic Kidney Disease Market

• 29.1. Africa Diabetic Kidney Disease Market Overview
• 29.2. Africa Diabetic Kidney Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Diabetic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Diabetic Kidney Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Diabetic Kidney Disease Market Competitive Landscape And Company Profiles

• 30.1. Diabetic Kidney Disease Market Competitive Landscape
• 30.2. Diabetic Kidney Disease Market Company Profiles
  • 30.2.1. AstraZeneca plc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Pfizer Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Novartis AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Sanofi SA
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Diabetic Kidney Disease Market Competitive Benchmarking

32. Global Diabetic Kidney Disease Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Diabetic Kidney Disease Market

34. Diabetic Kidney Disease Market Future Outlook and Potential Analysis

• 34.1 Diabetic Kidney Disease Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Diabetic Kidney Disease Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Diabetic Kidney Disease Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer